Skip to content
★ Sign in to follow
SP
Total declarations
118
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (85 ops.)
€4.3M

Latest filing published 02 Aug 2007 for SYNAPTICS Inc, €5,726.

Insider track record

Disclosed buys
0
Disclosed sells
85
Signal history

No signal scores available.

Shawn P. Day PhD: trading record in brief

All filings by Shawn P. Day PhD on record concern SYNAPTICS Inc. Over a trading history stretching from 3 January 2006 to 31 July 2007, the count stands at 118 filings.

No open-market purchase appears, only 85 sales worth €4.3M. Other entries cover 2 share grants and 31 option exercises. In 2007 alone, the filings show no purchases and 42 sales.

The latest filing, published on 2 August 2007, reports a share grant of €5,726 in SYNAPTICS Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Shawn P. Day PhD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations116 total
  • ◆
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    7,832 USD0SEC
    223 shares@ US$35.12Common StockSEC:0001209191-07-045537:0
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    49,800 USD0SEC
    5,000 shares@ US$9.96Common StockSEC:0001209191-07-042382:0
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    273,900 USD0SEC
    15,000 shares@ US$18.26Common StockSEC:0001209191-07-042382:1
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    215,000 USD0SEC
    10,000 shares@ US$21.50Common StockSEC:0001209191-07-042382:2
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    845,169 USD0SEC
    21,671 shares@ US$39.00Common StockSEC:0001209191-07-042382:3
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    324,914 USD0SEC
    8,329 shares@ US$39.01Common StockSEC:0001209191-07-042382:4
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    30,000 USD0SEC
    5,000 shares@ US$6.00Common StockSEC:0001209191-07-040756:0
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    199,200 USD0SEC
    20,000 shares@ US$9.96Common StockSEC:0001209191-07-040756:1
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    179,050 USD0SEC
    5,000 shares@ US$35.81Common StockSEC:0001209191-07-040756:2
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    671,600 USD0SEC
    18,400 shares@ US$36.50Common StockSEC:0001209191-07-040756:3
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    29,208 USD0SEC
    800 shares@ US$36.51Common StockSEC:0001209191-07-040756:4
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    29,216 USD0SEC
    800 shares@ US$36.52Common StockSEC:0001209191-07-040756:5
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    42,500 USD0SEC
    5,000 shares@ US$8.50Common StockSEC:0001209191-07-036425:0
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    90,000 USD0SEC
    15,000 shares@ US$6.00Common StockSEC:0001209191-07-036425:1
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    527,000 USD0SEC
    15,500 shares@ US$34.00Common StockSEC:0001209191-07-036425:2
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    153,045 USD0SEC
    4,500 shares@ US$34.01Common StockSEC:0001209191-07-036425:3
  • ◇
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    42,500 USD0SEC
    5,000 shares@ US$8.50Common StockSEC:0001209191-07-035333:0
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    6,344 USD0SEC
    200 shares@ US$31.72Common StockSEC:0001209191-07-035333:1
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    105,090 USD0SEC
    3,312 shares@ US$31.73Common StockSEC:0001209191-07-035333:2
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    47,229 USD0SEC
    1,488 shares@ US$31.74Common StockSEC:0001209191-07-035333:3
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    3,042 USD0SEC
    100 shares@ US$30.42Common StockSEC:0001209191-07-032397:0
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    368,659 USD0SEC
    12,111 shares@ US$30.44Common StockSEC:0001209191-07-032397:1
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    88,305 USD0SEC
    2,900 shares@ US$30.45Common StockSEC:0001209191-07-032397:2
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    39,598 USD0SEC
    1,300 shares@ US$30.46Common StockSEC:0001209191-07-032397:3
  • ▼
    VP of Research and DevelopmentExecutivesSYNAPTICS Inc
    54,846 USD0SEC
    1,800 shares@ US$30.47Common StockSEC:0001209191-07-032397:4

25 of 116 declarations